1. Huang, Z, Jiang, Q, Wang, Y, et al. SARS-CoV-2 inactivated vaccine (vero cells) shows good safety in repeated administration toxicity test of Sprague Dawley rats. Food Chem Toxicol. 2021;152:112239.
Google Scholar | Crossref | Medline2. Hao, X, Cheng, S, Wu, D, Wu, T, Lin, X, Wang, C. Reconstruction of the full transmission dynamics of COVID-19 in Wuhan. Nature. 2020;584(7821):420–424.
Google Scholar | Crossref | Medline3. Zhao, H, Lu, X, Deng, Y, Tang, Y, Lu, J. COVID-19: asymptomatic carrier transmission is an underestimated problem. Epidemiol Infect. 2020;148:e116.
Google Scholar | Crossref | Medline4. Dagan, N, Barda, N, Kepten, E, et al. BNT162b2 mRNA covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412–1423.
Google Scholar | Crossref | Medline5. Al-Kassmy, J, Pedersen, J, Kobinger, G. Vaccine candidates against coronavirus infections. Where does COVID-19 stand? Viruses. 2020;12(8):861.
Google Scholar | Crossref6. Conforti, A, Marra, E, Palombo, F, et al. COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 receptor binding domain, elicits protective immune responses in animal models of COVID-19. biorxiv. 2021. doi:10.1101/2021.06.1114.448343v1
Google Scholar7. Aurisicchio, L, Mancini, R, Ciliberto, G. Cancer vaccination by electro-gene-transfer. Expert Rev Vaccines. 2013;12(10):1127–1137.
Google Scholar | Crossref | Medline8. Bernelin-Cottet, C, Urien, C, McCaffrey, J, et al. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs. J Control Release. 2019;308:14–28.
Google Scholar | Crossref | Medline9. Hobernik, D, Bros, M. DNA vaccines-how far from clinical use?. Int J Mol Sci. 2018;19(11):3605.
Google Scholar | Crossref10. Rauch, S, Jasny, E, Schmidt, KE, Petsch, B. New vaccine technologies to combat outbreak situations. Front Immunol. 2018;9:1963.
Google Scholar | Crossref | Medline11. Suschak, JJ, Williams, JA, Schmaljohn, CS. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity. Hum Vaccin Immunother. 2017;13(12):2837–2848.
Google Scholar | Crossref | Medline12. Babiuk, S, Baca-Estrada, ME, Foldvari, M, et al. Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol. 2004;110(1):1–10.
Google Scholar | Crossref | Medline13. Calvet, CY, Andre, FM, Mir, LM. Dual therapeutic benefit of electroporation-mediated DNA vaccination in vivo: enhanced gene transfer and adjuvant activity. Oncoimmunology. 2014;3:e28540.
Google Scholar | Crossref | Medline14. Schultheis, K, Smith, TRF, Kiosses, WB, et al. Delineating the cellular mechanisms associated with skin electroporation. Hum Gene Ther Methods. 2018;29(4):177–188.
Google Scholar | Crossref | Medline15. Todorova, B, Adam, L, Culina, S, et al. Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques. Sci Rep. 2017;7(1):4122.
Google Scholar | Crossref | Medline16. Sun, Y, Gruber, M, Matsumoto, M. Overview of global regulatory toxicology requirements for vaccines and adjuvants. J Pharmacol Toxicol Methods. 2012;65(2):49–57.
Google Scholar | Crossref | Medline17. Forster, R . Study designs for the nonclinical safety testing of new vaccine products. J Pharmacol Toxicol Methods. 2012;66(1):1–7.
Google Scholar | Crossref | Medline18. Sellers, RS, Nelson, K, Bennet, B, et al. Scientific and regulatory policy committee points to consider*: approaches to the conduct and interpretation of vaccine safety studies for clinical and anatomic pathologists. Toxicol Pathol. 2020;48(2):257–276.
Google Scholar | SAGE Journals | ISI19. World Health Organization . WHO guidelines on nonclinical evaluation of vaccines. Technical Report Series, No. 927. 2021.
Google Scholar20. Schafer, KA, Eighmy, J, Fikes, JD, et al. Use of severity grades to characterize histopathologic changes. Toxicol Pathol. 2018;46(3):256–265.
Google Scholar | SAGE Journals | ISI21. van Doremalen, N, Lambe, T, Spencer, A, et al. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2020;586(7830):578–582.
Google Scholar | Crossref | Medline22. Vanker, N, Ipp, H. Large unstained cells: a potentially valuable parameter in the assessment of immune activation levels in HIV infection. Acta Haematol. 2014;131(4):208–212.
Google Scholar | Crossref | Medline23. Cray, C, Zaias, J, Altman, NH. Acute phase response in animals: a review. Comp Med. 2009;59(6):517–526.
Google Scholar | Medline | ISI24. Reagan, WJ, Shoieb, AM, Schomaker, SJ, Markiewicz, VR, Clarke, DW, Sellers, RS. Evaluation of rat acute phase proteins as inflammatory biomarkers for vaccine nonclinical safety studies. Toxicol Pathol. 2020;48(7):845–856.
Google Scholar | SAGE Journals | ISI25. Elmore, SA . Histopathology of the lymph nodes. Toxicol Pathol. 2006;34(5):425–454.
Google Scholar | SAGE Journals | ISI26. Kotnik, T, Frey, W, Sack, M, Haberl Meglic, S, Peterka, M, Miklavcic, D. Electroporation-based applications in biotechnology. Trends Biotechnol. 2015;33(8):480–488.
Google Scholar | Crossref | Medline27. Liu, J, Kjeken, R, Mathiesen, I, Barouch, DH. Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J Virol. 2008;82(11):5643–5649.
Google Scholar | Crossref | Medline28. Almeida, CF, Vainzof, M. Skeletal muscle injury by electroporation: a model to study degeneration/regeneration pathways in muscle. Methods Mol Biol. 2020;2063:157–169.
Google Scholar | Crossref | Medline29. Molnar, MJ, Gilbert, R, Lu, Y, et al. Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles. Mol Ther. 2004;10(3):447–455.
Google Scholar | Crossref | Medline30. Skuk, D, Goulet, M, Tremblay, JP. Electroporation as a method to induce myofiber regeneration and increase the engraftment of myogenic cells in skeletal muscles of primates. J Neuropathol Exp Neurol. 2013;72(8):723–734.
Google Scholar | Crossref | Medline31. Dolter, KE, Evans, CF, Ellefsen, B, et al. Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation. Vaccine. 2011;29(4):795–803.
Google Scholar | Crossref | Medline